COMMUNIQUÉS West-GlobeNewswire

TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
08/07/2026
TAIPEI, July 07, 2026 (GLOBE NEWSWIRE) -- TaiMed Biologics (TPEX: 4147) announced today that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) has officially received a Drug [...]
Acquisition of Own Shares
07/07/2026
Mechelen, Belgium; 07 July 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
07/07/2026
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum drives second quarter global preliminary net revenue of €7.7 million CMS proposes 2027 OPPS and ASC payment increase of [...]
Memocept Supplement Facts Analysis: Latest Consumer Safety Report Issued Regarding Ingredients' Effectiveness & Side Effects Risk
07/07/2026
Ogden, UT, July 07, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. Memocept is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified [...]
Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases
07/07/2026
CHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
Procès verbal AGE - 29 juin 2026
07/07/2026
Procès verbal de l'AGE du 29 juin 2026. Pièce jointe IBA - AGE 2026-06-29 définitive Ion Beam Applications
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2026
07/07/2026
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Ipsen - Half year statement - 2026 06 30
07/07/2026
Half-year statement of the liquidity agreement between IPSEN SA and NATIXIS ODDO BHF PARIS, 07 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that under the liquidity agreement entrusted by IPSEN S.A. to [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026
07/07/2026
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Erdem Hospital Launches UK Patient Community with First London Wellness Event
07/07/2026
The Istanbul-based healthcare group hosted its first UK wellness gathering in London, bringing together former patients and individuals interested in wellbeing for an afternoon of movement, relaxation and connection [...]
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
07/07/2026
TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA nephropathy (IgAN [...]
Legend Senior Living Deepens Commitment to Oklahoma Seniors with The Stonehaven of Oklahoma City
07/07/2026
WICHITA, Kan., July 07, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living will welcome The Stonehaven of Oklahoma City, formerly known as The Harrison, to its growing family of senior living communities. Located in south [...]
Ipsen - Bilan semestriel - 30 juin 2026
07/07/2026
Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF PARIS, FRANCE, 07 JUILLET 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd'hui qu’au titre du contrat de liquidité confié par IPSEN S.A [...]
Applied Biologics Announces VA Federal Supply Schedule Contract Modification Supporting Long-Term Access to XWRAP®
07/07/2026
SCOTTSDALE, Ariz., July 07, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced that the [...]
PDV MedTech et Corscience annoncent un partenariat stratégique visant à faire progresser le développement et la fabrication de technologies médicales aux États-Unis et en Europe
07/07/2026
Cette collaboration associe l’expertise européenne en développement aux capacités de fabrication américaines afin d’offrir aux innovateurs du secteur des technologies médicales un parcours fluide, de la conception à la [...]
Catalyst MedTech Announces Channel Partnership with APQ Health to Expand Access to Advanced Cardiac CT Analysis
07/07/2026
PITTSBURGH, July 07, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced a strategic channel partnership with APQ Health to expand access to advanced [...]
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1
07/07/2026
Completion of enrollment anticipated within 12 months GALILEO-3 is intended to support the registration of FLT201 in the adult GD1 population LONDON, July 07, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced [...]
Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026
07/07/2026
Nu-Tek présentera des données démontrant comment ses nutriments pour milieux de culture sans composants d’origine animale améliorent le rendement, optimisent les procédés et renforcent la sécurité d’approvisionnement [...]
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
07/07/2026
MIAMI, July 07, 2026 (GLOBE NEWSWIRE) -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical [...]

Pages